Prokaryoplankton genomes from the deep marine sediments are much less explored in comparison with shallow shore sediments. The Gulfs of Kathiawar peninsula expertise various currents and inputs from completely different on-shore actions. Any perturbations would straight affect the microbiome and their regular homeostasis.
Developments in reconstructing genomes from metagenomes permits us to know the position of particular person unculturable microbes in ecological niches just like the Gulf sediments. Right here, we report 309 bacterial and archaeal genomes assembled from metagenomics knowledge of deep sediments from websites within the Gulf of Khambhat and Gulf of Kutch in addition to a pattern from the Arabian Sea. Phylogenomics labeled them into 5 archaeal and 18 bacterial phyla. The genomes will facilitate understanding of the physiology, adaptation and influence of on-shore anthropogenic actions on the deep sediment microbes.
Growing Bioprospecting Methods for Bioplastics By the Giant-Scale Mining of Microbial Genomes
The buildup of petroleum-based plastic waste has change into a significant situation for the setting. A sustainable and biodegradable resolution will be present in Polyhydroxyalkanoates (PHAs), a microbially produced biopolymer. An evaluation of the worldwide phylogenetic and ecological distribution of potential PHA producing micro organism and archaea was carried out by mining a world genome repository for PHA synthase (PhaC), a key enzyme concerned in PHA biosynthesis.
Micro organism from the phylum Actinobacteria had been discovered to comprise the PhaC Class II genotype which produces medium-chain size PHAs, a physiology till now solely discovered inside a number of Pseudomonas species. Additional, a number of PhaC genotypes had been found inside Thaumarchaeota, an archaeal phylum with poly-extremophiles and the power to effectively use CO2 as a carbon supply, a major ecological group which have to date been little studied for PHA manufacturing. Bacterial and archaeal PhaC genotypes had been additionally noticed in excessive salinity and alkalinity circumstances, in addition to high-temperature geothermal ecosystems.
These genome mining efforts uncovered beforehand unknown candidate taxa for biopolymer manufacturing, in addition to microbes from environmental niches with properties that might doubtlessly enhance PHA manufacturing. This in silico examine gives priceless insights into distinctive PHA producing candidates, supporting future bioprospecting efforts towards higher focused and related taxa to additional improve the range of exploitable PHA manufacturing programs.
Geography, Host Genetics, and Cross-Area Microbial Networks Construction the Pores and skin Microbiota of Fragmented Brazilian Atlantic Forest Frog Populations
The host-associated microbiome performs a major position in well being. Nonetheless, the roles of things corresponding to host genetics and microbial interactions in figuring out microbiome range stay unclear. We examined these components utilizing amplicon-based sequencing of 175 Thoropa taophora frog pores and skin swabs collected from a naturally fragmented panorama in southeastern Brazil.
Particularly, we examined (1) the results of geography and host genetics on microbiome range and construction; (2) the construction of microbial eukaryotic and bacterial co-occurrence networks; and (3) co-occurrence between microeukaryotes with bacterial OTUs identified to have an effect on progress of the fungal pathogen Batrachochytrium dendrobatidis (Bd).
Whereas bacterial alpha range various by each web site kind and host MHC IIB genotype, microeukaryotic alpha range various solely by web site kind. Nonetheless, micro organism and microeukaryote composition confirmed variation in line with each web site kind and host MHC IIB genotype. Our community evaluation confirmed the best connectivity when each eukaryotes and micro organism had been included, implying that ecological interactions might happen amongst domains.
Lastly, anti-Bd micro organism weren’t broadly negatively co-associated with the fungal microbiome and had been positively related to potential amphibian parasites. Our findings emphasize the significance of contemplating each domains in microbiome analysis and recommend that for efficient probiotic methods for amphibian illness administration, contemplating potential interactions amongst all members of the microbiome is essential.
Eight metagenome-assembled genomes present proof for microbial adaptation in 20,000 to 1,000,000-year-old Siberian permafrost
Permafrost microbes could also be metabolically energetic in microscopic layers of liquid brines, even in historical soil. Metagenomics can assist discern whether or not permafrost microbes present variations to this setting. Thirty-three metagenome-assembled genomes (MAGs) had been obtained from six depths (3.5 m to 20 m) of freshly-cored permafrost from the Siberia Kolyma-Indigirka Lowland area. These soils have been constantly frozen for ∼20,000 to 1,000,000 years.
Eight of those MAGs had been ≥80% full with <10% contamination and had been taxonomically recognized as Aminicenantes, Atribacteria, Chloroflexi, and Actinobacteria inside micro organism and Thermoprofundales inside archaea. MAGs from these taxa have beforehand been obtained from non-permafrost environments and have been prompt to point out variations to long-term energy-starvation, however they’ve by no means been explored in historical permafrost. The permafrost MAGs had greater proportions of clusters of orthologous genes (COGs) from ‘Vitality manufacturing and conversion’ and ‘Carbohydrate transport and metabolism’ than their non-permafrost counterparts.
Additionally they contained genes for trehalose synthesis, thymine metabolism, mevalonate biosynthesis and cellulose degradation that had been much less prevalent in non-permafrost genomes. Many of those genes are concerned in membrane stabilization and osmotic stress responses, in step with adaptation to the anoxic, excessive ionic energy, chilly environments of permafrost brine movies. Our outcomes recommend that this historical permafrost comprises DNA in excessive sufficient high quality to assemble MAGs from microorganisms with variations to subsist long-term freezing on this excessive setting. Significance Permafrost all over the world is thawing quickly.
CD40LG/TNFSF5 (Cd40 Ligand) Antibody |
|||
| 20-abx111483 | Abbexa |
|
|
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-10ug | Novoprotein | 10ug | EUR 120 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-1mg | Novoprotein | 1mg | EUR 1131.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-500ug | Novoprotein | 500ug | EUR 808.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-50ug | Novoprotein | 50ug | EUR 230.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Human CellExp? CD40 Ligand / TNFSF5, Fc tag, Human Recombinant |
|||
| P1175-10 | Biovision | each | EUR 196.8 |
Human CellExp? CD40 Ligand / TNFSF5, Fc tag, Human Recombinant |
|||
| P1175-50 | Biovision | each | EUR 666 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-1mg |
|||
| QP8528-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-1mg |
|||
| QP9047-ye-1mg | EnQuireBio | 1mg | EUR 2262 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-10ug |
|||
| QP8528-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-50ug |
|||
| QP8528-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-10ug |
|||
| QP9047-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-50ug |
|||
| QP9047-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-100ug |
|||
| QP8528-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-200ug |
|||
| QP8528-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-500ug |
|||
| QP8528-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-100ug |
|||
| QP9047-ye-100ug | EnQuireBio | 100ug | EUR 576 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-200ug |
|||
| QP9047-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-500ug |
|||
| QP9047-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-1mg |
|||
| QP5332-1mg | EnQuireBio | 1mg | EUR 1633.2 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-10ug |
|||
| QP10359-ec-10ug | EnQuireBio | 10ug | EUR 184.8 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-50ug |
|||
| QP10359-ec-50ug | EnQuireBio | 50ug | EUR 348 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-500ug |
|||
| QP5332-500ug | EnQuireBio | 500ug | EUR 991.2 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-100ug |
|||
| QP10359-ec-100ug | EnQuireBio | 100ug | EUR 630 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-250ug |
|||
| QP10359-ec-250ug | EnQuireBio | 250ug | EUR 1077.6 |
Human Cluster of Differentiation 40 Ligand (CD40L/TNFSF5) CLIA Kit |
|||
| abx195380-96tests | Abbexa | 96 tests | EUR 990 |
Human CellExp? CD40 Ligand / TNFSF5 Protein, Fc Tag, Mouse recombinant |
|||
| P1127-10 | Biovision | each | EUR 170.4 |
Human CellExp? CD40 Ligand / TNFSF5 Protein, Fc Tag, Mouse recombinant |
|||
| P1127-50 | Biovision | each | EUR 574.8 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx050201-96tests | Abbexa | 96 tests | EUR 924 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx250223-96tests | Abbexa | 96 tests | EUR 801.6 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| 20-abx151003 | Abbexa |
|
|
Recombinant (E.coli) Human CD40 Ligand/CD40L/TNFSF5 (aa:108-261, His Tag, >95% Pure) |
|||
| HCD40L-15-N-10 | Alpha Diagnostics | 10 ug | EUR 255.6 |
Rhesus macaque CD40 Ligand / TNFSF5 Recombinant Protein |
|||
| 11-500 | ProSci | 0.1 mg | EUR 651.3 |
|
Description: CD40 ligand is also known as CD40L, CD154, TNFSF5 and T-cell antigen Gp39, is a single-pass type I I membrane protein which belongs to the TNF superfamily of molecules. CD40 ligand is expressed predominantly on activated CD4+ T lymphocytes, and also found in other types of cells, including platelets, mast cells, macrophages, basophils, NK cells, B lymphocytes, as well as non-haematopoietic cells (smooth muscle cells, endothelial cells, and epithelial cells). Although all monomeric, dimeric and trimeric forms of soluble CD40 ligand can bind to CD40, the trimeric form of soluble CD40 ligand has the most potent biological activity through oligomerization of cell surface CD40, a common feature of TNF receptor family members.CD40 ligand binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. In general, CD40 ligand plays the role of a costimulatory molecule and induces activation in APC in association with T cell receptor stimulation by MHC molecules on the APC. In total CD40 ligand has three binding partners: CD40, α5β1 integrin and αIIbβ3. CD40 ligand regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper IgM syndrome. |
|||
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, E.coli-1mg |
|||
| QP5787-ec-1mg | EnQuireBio | 1mg | EUR 2763.6 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, E.coli-10ug |
|||
| QP5787-ec-10ug | EnQuireBio | 10ug | EUR 391.2 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, E.coli-50ug |
|||
| QP5787-ec-50ug | EnQuireBio | 50ug | EUR 522 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, Yeast-1mg |
|||
| QP5787-ye-1mg | EnQuireBio | 1mg | EUR 3296.4 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, E.coli-100ug |
|||
| QP5787-ec-100ug | EnQuireBio | 100ug | EUR 848.4 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, E.coli-200ug |
|||
| QP5787-ec-200ug | EnQuireBio | 200ug | EUR 1338 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, E.coli-500ug |
|||
| QP5787-ec-500ug | EnQuireBio | 500ug | EUR 1816.8 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, Yeast-10ug |
|||
| QP5787-ye-10ug | EnQuireBio | 10ug | EUR 434.4 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, Yeast-50ug |
|||
| QP5787-ye-50ug | EnQuireBio | 50ug | EUR 576 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, Yeast-100ug |
|||
| QP5787-ye-100ug | EnQuireBio | 100ug | EUR 945.6 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, Yeast-200ug |
|||
| QP5787-ye-200ug | EnQuireBio | 200ug | EUR 1512 |
Recombinant Rabbit CD40L/ CD154/ TNFSF5 Protein, His, Yeast-500ug |
|||
| QP5787-ye-500ug | EnQuireBio | 500ug | EUR 2164.8 |
Recombinant Mouse CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-1mg |
|||
| QP5411-1mg | EnQuireBio | 1mg | EUR 3427.2 |
Recombinant Mouse CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-5ug |
|||
| QP5411-5ug | EnQuireBio | 5ug | EUR 163.2 |
Recombinant Mouse CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-25ug |
|||
| QP5411-25ug | EnQuireBio | 25ug | EUR 284.4 |
Recombinant Mouse CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-100ug |
|||
| QP5411-100ug | EnQuireBio | 100ug | EUR 588 |
Recombinant Mouse CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-500ug |
|||
| QP5411-500ug | EnQuireBio | 500ug | EUR 2133.6 |
CD40L/TNFSF5 ELISA Kit| Porcine Cluster of Differentiation 40 Li |
|||
| EF016575 | Lifescience Market | 96 Tests | EUR 826.8 |
CD40L/TNFSF5 ELISA Kit| Rabbit Cluster of Differentiation 40 Lig |
|||
| EF016786 | Lifescience Market | 96 Tests | EUR 826.8 |
CD40L/TNFSF5 ELISA Kit| Monkey Cluster of Differentiation 40 Lig |
|||
| EF012688 | Lifescience Market | 96 Tests | EUR 826.8 |
Pig Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| 20-abx154902 | Abbexa |
|
|
Rat Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| 20-abx155324 | Abbexa |
|
|
Pig Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx255448-96tests | Abbexa | 96 tests | EUR 990 |
Rat Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx256785-96tests | Abbexa | 96 tests | EUR 904.8 |
Dog Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| 20-abx156972 | Abbexa |
|
|
Cow Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx573306-96tests | Abbexa | 96 tests | EUR 1093.2 |
Rat Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx570365-96tests | Abbexa | 96 tests | EUR 904.8 |
Dog Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx570476-96tests | Abbexa | 96 tests | EUR 1111.2 |
Mouse Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| 20-abx153801 | Abbexa |
|
|
Monkey CD40L/TNFSF5(Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| EMK0014 | FN Test | 96T | EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Ape;Sensitivity: 0.094 ng/ml |
|||
Rabbit CD40L/TNFSF5(Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| ERB0026 | FN Test | 96T | EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rabbit;Sensitivity: 0.094 ng/ml |
|||
Mouse Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx254003-96tests | Abbexa | 96 tests | EUR 904.8 |
Mouse Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx574576-96tests | Abbexa | 96 tests | EUR 904.8 |
Porcine CD40L/TNFSF5(Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| EP0034 | FN Test | 96T | EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Pig;Sensitivity: 0.094 ng/ml |
|||
Rabbit Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx256991-96tests | Abbexa | 96 tests | EUR 990 |
Monkey Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx570479-96tests | Abbexa | 96 tests | EUR 990 |
Chicken Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx250036-96tests | Abbexa | 96 tests | EUR 990 |
Chicken Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx570477-96tests | Abbexa | 96 tests | EUR 990 |
Human TNFSF18 Antibody |
|||
| 32559-05111 | AssayPro | 150 ug | EUR 313.2 |
Human TNFSF18 Antibody |
|||
| 32752-05111 | AssayPro | 150 ug | EUR 313.2 |
anti- TNFSF12 antibody |
|||
| FNab08827 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against TNFSF12 |
|||
anti- TNFSF13 antibody |
|||
| FNab08828 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against TNFSF13 |
|||
anti- TNFSF14 antibody |
|||
| FNab08830 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against TNFSF14 |
|||
anti- TNFSF13B antibody |
|||
| FNab08829 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against TNFSF13B |
|||
Anti-TL1A/TNFSF15 Antibody |
|||
| A02402-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-TRAIL/Tnfsf10 Antibody |
|||
| A00466 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-TRAIL/TNFSF10 Antibody |
|||
| A00466-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-BAFF/TNFSF13B Antibody |
|||
| A01257 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-TWEAK/TNFSF12 Antibody |
|||
| A02009-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-LIGHT/Tnfsf14 Antibody |
|||
| A03516-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-RANKL/TNFSF11 Antibody |
|||
| PB10015 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-TRAIL/TNFSF10 Antibody |
|||
| PA1419 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-BAFF/TNFSF13B Antibody |
|||
| PA1541 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-TRAIL/TNFSF10 Antibody |
|||
| PB9060 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-APRIL/TNFSF13 Antibody |
|||
| PB9523 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-BAFF/TNFSF13B Antibody |
|||
| PB9567 | BosterBio | 100ug/vial | EUR 352.8 |
Recombinant Human TNFSF13B/TNFSF20 (N-Fc) |
|||
| CU71-10ug | Novoprotein | 10ug | EUR 187.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human TNFSF13B/TNFSF20 (N-Fc) |
|||
| CU71-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human TNFSF13B/TNFSF20 (N-Fc) |
|||
| CU71-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human TNFSF13B/TNFSF20 (N-Fc) |
|||
| CU71-50ug | Novoprotein | 50ug | EUR 442.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Human TNFSF18 Antibody (Biotin Conjugate) |
|||
| 32559-05121 | AssayPro | 150 ug | EUR 442.8 |
Human TNFSF18 Antibody (Biotin Conjugate) |
|||
| 32752-05121 | AssayPro | 150 ug | EUR 442.8 |
Anti-CD252/Tnfsf4 Antibody |
|||
| A02554-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-CD153/TNFSF8 Antibody |
|||
| RP1103 | BosterBio | 100ug/vial | EUR 400.8 |
Human TRAIL TNFSF10(TRAIL TNFSF10) ELISA Kit |
|||
| QY-E05428 | Qayee Biotechnology | 96T | EUR 433.2 |
Human TNFSF15 ELISA KIT |
|||
| ELI-41844h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF13 ELISA KIT |
|||
| ELI-05676h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF18 ELISA KIT |
|||
| ELI-51626h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF12 ELISA kit |
|||
| LF-EK50803 | Abfrontier | 1×96T | EUR 777.6 |
Human TNFSF14 ELISA Kit |
|||
| ELA-E2060h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF18 ELISA Kit |
|||
| ELA-E8960h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF11 ELISA KIT |
|||
| ELI-02900h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF11 ELISA Kit |
|||
| ELA-E0855h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF13 ELISA Kit |
|||
| ELA-E1750h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF12 ELISA Kit |
|||
| ELA-E1883h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF10 ELISA Kit |
|||
| ELA-E0139h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF12 ELISA KIT |
|||
| ELI-06037h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF14 ELISA KIT |
|||
| ELI-06607h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF11 ELISA Kit |
|||
| STJ150478 | St John's Laboratory | 1 kit | EUR 494.4 |
|
Description: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of sRANKL in human serum, plasma and other biological fluids |
|||
Human TNFSF18 AssayLite Antibody (RPE Conjugate) |
|||
| 32559-05151 | AssayPro | 150 ug | EUR 513.6 |
Human TNFSF18 AssayLite Antibody (APC Conjugate) |
|||
| 32559-05161 | AssayPro | 150 ug | EUR 513.6 |
Human TNFSF18 AssayLite Antibody (RPE Conjugate) |
|||
| 32752-05151 | AssayPro | 150 ug | EUR 513.6 |
Human TNFSF18 AssayLite Antibody (APC Conjugate) |
|||
| 32752-05161 | AssayPro | 150 ug | EUR 513.6 |
Human TNFSF13B ELISA KIT |
|||
| ELI-05502h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF13B ELISA Kit |
|||
| ELA-E1686h | Lifescience Market | 96 Tests | EUR 988.8 |
RANK L/TNFSF11, Human |
|||
| HY-P7424 | MedChemExpress | 50ug | EUR 1410 |
Human TNFSF18 AssayLite Antibody (FITC Conjugate) |
|||
| 32559-05141 | AssayPro | 150 ug | EUR 513.6 |
Human TNFSF18 AssayLite Antibody (FITC Conjugate) |
|||
| 32752-05141 | AssayPro | 150 ug | EUR 513.6 |
Human TNFSF18 AssayLite Antibody (PerCP Conjugate) |
|||
| 32559-05171 | AssayPro | 150 ug | EUR 565.2 |
Human TNFSF18 AssayLite Antibody (PerCP Conjugate) |
|||
| 32752-05171 | AssayPro | 150 ug | EUR 565.2 |
ELISA kit for Human TNFSF12 |
|||
| EK5413 | SAB | 96 tests | EUR 663.6 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human TNFSF12 in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
TNFSF18 (Human) ELISA Kit |
|||
| K4235-100 | Biovision | each | EUR 966 |
TNFSF10 ELISA KIT|Human |
|||
| EF007175 | Lifescience Market | 96 Tests | EUR 826.8 |
Human TNFSF12 ELISA kit (4×96T) |
|||
| LF-EK50804 | Abfrontier | 4×96T | EUR 2641.2 |
Human TNFSF15 shRNA Plasmid |
|||
| 20-abx956703 | Abbexa |
|
|
Human TNFSF11 shRNA Plasmid |
|||
| 20-abx955648 | Abbexa |
|
|
Human TNFSF14 shRNA Plasmid |
|||
| 20-abx955758 | Abbexa |
|
|
Human TNFSF13 shRNA Plasmid |
|||
| 20-abx955759 | Abbexa |
|
|
Human TNFSF12 shRNA Plasmid |
|||
| 20-abx955760 | Abbexa |
|
|
Human TNFSF10 shRNA Plasmid |
|||
| 20-abx955761 | Abbexa |
|
|
Human TNFSF18 shRNA Plasmid |
|||
| 20-abx955936 | Abbexa |
|
|
Rat anti Mouse TNFSF12 monoclonal antibody |
|||
| CABT-L330 | Creative Diagnostics | 500ug | EUR 982.8 |
Human TNFSF13/APRIL ELISA kit |
|||
| LF-EK50805 | Abfrontier | 1×96T | EUR 777.6 |
Human TNFSF11/RANKL ELISA Kit |
|||
| LF-EK50929 | Abfrontier | 1×96T | EUR 777.6 |
Human CD70 Antigen / TNFSF7 (CD70) ELISA Kit |
|||
| 20-abx153329 | Abbexa |
|
|
Human CD70 Antigen / TNFSF7 (CD70) ELISA Kit |
|||
| abx555551-96tests | Abbexa | 96 tests | EUR 886.8 |
Human TNFSF13B shRNA Plasmid |
|||
| 20-abx957280 | Abbexa |
|
|
Human TNFSF9 ELISA KIT |
|||
| ELI-45503h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF4 ELISA Kit |
|||
| ELA-E8964h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF7 ELISA Kit |
|||
| ELA-E9131h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF8 ELISA Kit |
|||
| ELA-E0118h | Lifescience Market | 96 Tests | EUR 988.8 |
Human TNFSF4 ELISA KIT |
|||
| ELI-07649h | Lifescience Market | 96 Tests | EUR 988.8 |
ELISA kit for Human TNFSF11/RANKL |
|||
| EK5377 | SAB | 96 tests | EUR 663.6 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human TNFSF11/RANKL in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
ELISA kit for Human TNFSF13/APRIL |
|||
| EK5414 | SAB | 96 tests | EUR 663.6 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human TNFSF13/APRIL in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
ELISA kit for Human TNFSF14/LIGHT |
|||
| EK5462 | SAB | 96 tests | EUR 663.6 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human TNFSF14/LIGHT in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Human TNFSF13/APRIL EZ-Set™ ELISA Kit (DIY Antibody Pairs) |
|||
| EZ0921 | BosterBio | 5 plates/kit | EUR 321.6 |
|
Description: NA |
|||
Human TNFSF12 PicoKine ELISA Kit |
|||
| EK0920 | BosterBio | 96 wells | EUR 510 |
|
Description: For quantitative detection of human TNFSF12 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
|||
Many scientists from a wide range of disciplines have proven the significance of understanding what is going to occur to our ecosystem, commerce, and local weather when permafrost thaws. The destiny of permafrost microorganisms is related to those predicted speedy environmental modifications. Finding out historical permafrost with tradition unbiased strategies may give a glimpse into how these microorganisms operate in these excessive low temperature and vitality circumstances. This can help understanding of how they are going to change with the setting. This examine presents genomic knowledge from this distinctive setting aged ∼20,000 to 1,000,000-years-old.